There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Trevena (TRVN – Research Report) and Nkarta (NKTX – Research Report) with bullish sentiments.
Trevena (TRVN)
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Trevena today and set a price target of $1.50. The company’s shares closed last Thursday at $0.24, close to its 52-week low of $0.18.
According to TipRanks.com, Tsao is a 3-star analyst with an average return of
Currently, the analyst consensus on Trevena is a Moderate Buy with an average price target of $1.75, a 600.0% upside from current levels. In a report issued on July 28, JMP Securities also reiterated a Buy rating on the stock with a $4.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Nkarta (NKTX)
In a report released today, Gil Blum from Needham maintained a Buy rating on Nkarta, with a price target of $26.00. The company’s shares closed last Thursday at $15.60.
According to TipRanks.com, Blum is a 1-star analyst with an average return of
Currently, the analyst consensus on Nkarta is a Strong Buy with an average price target of $41.83, implying a 162.1% upside from current levels. In a report released today, Mizuho Securities also maintained a Buy rating on the stock with a $81.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TRVN:
- Analysts Have Conflicting Sentiments on These Technology Companies: Viavi Solutions (VIAV), Rigetti Computing (RGTI) and Rockley Photonics Holdings (RKLY)
- MAVERIX ANNOUNCES SECOND QUARTER 2022 RESULTS AND DECLARES QUARTERLY DIVIDEND
- These Stocks Are the Biggest Pre-Market Movers on Friday
- Siebert Williams Shank & Co Sticks to Their Hold Rating for Heliogen (HLGN)
- Rosenblatt Securities Sticks to Its Buy Rating for Six Flags (SIX)
